openPR Logo
Press release

United States Novel Drug Delivery System Market Reimagines Therapeutic Delivery with Adaptive Technologies

01-28-2026 08:18 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Novel Drug Delivery System Market Size

Novel Drug Delivery System Market Size

DataM Intelligence has published a new research report on "Novel Drug Delivery System Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/novel-drug-delivery-system-market?kb

(Single User Report: USD 3480 & One Year Database Subscription: USD 10K)

Latest M&A Highlights

✅ Biogen completes acquisition of Alcyone Therapeutics, securing the intrathecal delivery technology ThecaFlex DRx to enhance its drug delivery solutions and pipeline.

✅ German drug delivery specialist LTS Lohmann buys CDMO Renaissance Lakewood, expanding its U.S. contract manufacturing footprint for drug delivery systems.

Key Players:

Abbott Laboratories, Pfizer Inc, Johnson & Johnson Inc, F. Hoffmann-La Roche AG, Bristol-Myers Squibb, Novartis AG, Baxter, Spectrum Pharmaceuticals Inc, Boston Scientific Corporation, and AstraZeneca PLC.

Key Development:

January 2026

. MedTech Pharma launched an advanced nanoparticle-based delivery platform enhancing targeted cancer therapy efficacy.

. BioNext and PharmaGen inked a strategic partnership to develop sustained-release injectable formulations.

December 2025

. FDA approved the first oral mRNA delivery system for rare genetic diseases, marking a significant milestone.

. NanoMed Inc. secured $50M Series B funding to accelerate clinical trials of its microneedle patch technology.

November 2025

. Global Pharma unveiled a new implantable device for continuous insulin delivery, promising better glycemic control.

. Research published in Journal of Controlled Release highlights breakthroughs in biodegradable polymer carriers for sustained drug delivery.

Growth Forecast Projected:

The Global Novel Drug Delivery System Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Novel Drug Delivery System Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=novel-drug-delivery-system-market?kb

Key Segments:

By Route of Administration: Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, Others

By Mode: Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems

By Indication: Oncology, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Neurological Disorders, Others

By End-User: Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Home Care Settings, Academic Research Institutes, Others

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/novel-drug-delivery-system-market?kb

(Single User Report: USD 3480 & One Year Database Subscription: USD 10K)

FAQ

Q1: What is the current size of the Novel Drug Delivery System Market?

A: The Novel Drug Delivery System Market was valued at US$ 12.6 billion in 2022 and is forecasted to reach US$ 55.7 billion by 2030

Q2: How rapidly will the Market expand?

A: The Novel Drug Delivery System market is projected to grow at a CAGR of 21.2% between 2025 and 2032.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?kb

Contact Us For Exclusive Information: https://www.datamintelligence.com/contact?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Novel Drug Delivery System Market Reimagines Therapeutic Delivery with Adaptive Technologies here

News-ID: 4366225 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Neuromarketing Market to Reach US$ 3.52 Billion by 2032 at 9.21% CAGR; North America Leads with 40% Share | Key Players Nielsen Consumer, Affectiva, Immersion Neuroscience
Neuromarketing Market to Reach US$ 3.52 Billion by 2032 at 9.21% CAGR; North Ame …
The neuromarketing market reached US$ 1.74 billion in 2024 and is expected to reach US$ 3.52 billion by 2032, growing at a CAGR of 9.21% during the forecast period 2025-2032. The market is gaining traction as brands seek data-driven insights into consumer behavior, emotions, and decision-making to improve advertising effectiveness and brand engagement across digital and traditional platforms. Growth is particularly strong in North America, driven by high investments in neuroscience-based
Lab-on-a-Chip Market to Reach US$ 14.66 Billion by 2032 at 10.12% CAGR; North America Leads with 42% Share | Key Players Thermo Fisher Scientific, Illumina, Danaher
Lab-on-a-Chip Market to Reach US$ 14.66 Billion by 2032 at 10.12% CAGR; North Am …
The Lab-on-a-Chip market reached US$ 6.78 billion in 2024 and is expected to reach US$ 14.66 billion by 2032, growing at a CAGR of 10.12% during the forecast period 2025-2032. Market growth is driven by the increasing demand for rapid, portable, and cost-effective diagnostic solutions across healthcare, pharmaceutical, and research applications. Lab-on-a-chip (LoC) devices integrate multiple laboratory functions onto a single microchip, enabling fast and accurate diagnostics using minimal sample
Vitamin D Market to Reach US$ 2.42 Billion by 2032 at 7.86% CAGR, Driven by Rising Deficiency Awareness and Demand in Supplements & Functional Foods | DataM Intelligence
Vitamin D Market to Reach US$ 2.42 Billion by 2032 at 7.86% CAGR, Driven by Risi …
According to DataM Intelligence, the global Vitamin D market reached US$ 1.32 billion in 2024 and is expected to reach US$ 2.42 billion by 2032, growing at a CAGR of 7.86% during the forecast period 2025-2032, driven by increasing prevalence of vitamin D deficiency, strong consumer demand for immune support and bone health supplements, growing use of vitamin D3 in pharmaceuticals and animal feed, expanding applications in food & beverage
United States Rigid Industrial Packaging Market Reinvents Bulk Packaging with Intelligent, Eco-Friendly Materials
United States Rigid Industrial Packaging Market Reinvents Bulk Packaging with In …
DataM Intelligence has published a new research report on "Rigid Industrial Packaging Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Get a Sample PDF Of This Report

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase